Chiron Investment Management, LLC Bio Techne Corp Transaction History

Chiron Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $142,224 - $214,422	-767 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $37,936 - $44,418	-200 Reduced 20.68%	767 $168,000
Q2 2019 Aug 14, 2019	SELL	$188.72 - $215.43 $18,872 - $21,543	-100 Reduced 9.37%	967 $202,000
Q1 2019 May 14, 2019	SELL	$136.09 - $200.44 $54,436 - $80,176	-400 Reduced 27.27%	1,067 $212,000
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $92,925 - $142,660	700 Added 91.26%	1,467 $212,000
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $142,869 - $197,782	-969 Reduced 55.82%	767 $157,000
Q2 2018 Aug 13, 2018	BUY	$144.9 - $165.58 $126,932 - $145,048	876 Added 101.86%	1,736 $257,000
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $113,055 - $129,894	860 New	860 $130,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.79B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chiron Investment Management, LLC with notifications on news.